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The	biological	basis	for	regional	and	inter-species	differences	in	
cerebral	cortical	morphology	is	poorly	understood.	We	focused	
on	consanguineous	Turkish	families	with	a	single	affected	
member	with	complex	bilateral	occipital	cortical	gyration	
abnormalities.	By	using	whole-exome	sequencing,	we	initially	
identified	a	homozygous	2-bp	deletion	in	LAMC3,	the	laminin	3	
gene,	leading	to	an	immediate	premature	termination	codon.	
In	two	other	affected	individuals	with	nearly	identical	
phenotypes,	we	identified	a	homozygous	nonsense	mutation	
and	a	compound	heterozygous	mutation.	In	human	but	not	
mouse	fetal	brain,	LAMC3	is	enriched	in	postmitotic	cortical	
plate	neurons,	localizing	primarily	to	the	somatodendritic	
compartment.	LAMC3	expression	peaks	between	late	gestation	
and	late	infancy,	paralleling	the	expression	of	molecules	that	
are	important	in	dendritogenesis	and	synapse	formation.	
The	discovery	of	the	molecular	basis	of	this	unusual	occipital	
malformation	furthers	our	understanding	of	the	complex	
biology	underlying	the	formation	of	cortical	gyrations.
Extensive and stereotypic gyrations (convolutions) of the cerebral 
cortex are striking features of the human brain1,2. The cerebral cor-
tex develops through a series of highly coordinated phases including 
proliferation of neural progenitors, migration of postmitotic cells 
from the germinal matrix to the newly forming cortex and organiza-
tion of the mature cortical cytoarchitecture. Among these processes, 
the biological basis for the formation of cortical convolutions has 
been the subject of much debate3–7. The study of malformations of 
cortical development (MCD) that interfere with the proper forma-
tion of the typical cortical gyration pattern in humans provides a 
unique opportunity to understand this elegant process. We applied 
whole-exome capture and sequencing to the study of consanguine-
ous, single-affected–member Turkish kindreds with malformations 
of occipital cortex gyration, notably characterized by the presence of 
both pachygyria and polymicrogyria8,9, entities traditionally thought 
to arise from different pathogenic mechanisms reflecting abnormali-
ties in neuronal migration and cortical organization, respectively10.
The first index case, designated NG 49-1 (Fig. 1a, Supplementary 
Fig. 1 and Supplementary Note), presented to medical attention with 
absence seizures and mild developmental delay during early child-
hood. Magnetic resonance imaging (MRI) revealed bilateral occipital 
pachygyria mainly localizing to the lateral surface, characterized by 
smoothening of the occipital cortices with loss of secondary and ter-
tiary gyri, and polymicrogyric areas, characterized by the formation 
of numerous small gyri at the junction of the parieto-occipital lobes 
(Fig. 1b–f and Supplementary Videos 1 and 2). Following genome-
wide genotyping, which confirmed consanguinity with an inbreeding 
coefficient of 5.77, and determination of homozygous genomic seg-
ments (>2.5 cM each) (Supplementary Table 1), we performed whole-
exome capture and sequencing with high sensitivity and specificity using 
NimbleGen liquid-phase arrays and the Illumina Genome Analyzer-IIx 
instrument as described previously11 (Supplementary Tables 2 and 3). 
By focusing on the homozygous intervals (Supplementary Table 4), 
we identified a homozygous 2-bp deletion in LAMC3 (Laminin γ3), 
which is located on chromosome 9; this mutation is inferred to result 
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in a frameshift at codon 301 (of the 1,575 total encoded amino acids) 
and lead to an immediate premature termination (p.Cys301X) (Fig. 1g 
and Supplementary Fig. 2). Both parents were heterozygous for 
the variant (Supplementary Fig. 2a). These results suggested that 
the homozygous LAMC3 variant was the disease-causing mutation 
in this family.
We then searched for additional mutations in a cohort of 12 indi-
viduals with MCD with homozygosity of at least 2.5 cM spanning 
LAMC3. Only one of these individuals (NG 367-1) had a diagnosis 
of occipital pachygyria, whereas the others were referred with various 
MCD phenotypes including polymicrogyria or lissencephaly, or were 
not otherwise specified. Sanger sequencing of the complete coding 
region of LAMC3 in these individuals revealed only one previously 
unidentified, homozygous mutation at codon 157 resulting in pre-
mature termination (p.Trp157X) in the subject with the diagnosis 
of occipital pachygyria (NG 367-1) (Fig. 2a,b and Supplementary 
Fig. 2b). Both parents of this individual were heterozygous for the 
variant (Supplementary Fig. 2b). Subject NG 367-1 had a phenotype 
almost identical to the first index case, NG 49-1 (Fig. 1), presenting 
to medical attention at age 10 years with seizures largely consisting of 
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visualized in c and d, in which the white arrowheads mark the preserved calcarine fissure. Panels d and f are enlarged views of c and e, respectively. 
Photographically inverted T2 images are shown. (g) Exome sequencing shows a 2-bp ‘TG’ deletion (marked in red in the wild-type (WT) sequence on top) 
in the LAMC3. The depth of coverage across the variant was 28×, and all but one of the reads showed the deletion.
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Figure 2 Additional LAMC3 mutations in individuals with occipital 
cortical malformation. (a) Simplified pedigree structure of NG 367 
(arrow, index case) shows a first cousin consanguineous union. (b) Axial, 
enlarged axial and sagittal magnetic resonance images reveal cortical 
smoothening and thickening limited to the bilateral occipital cortices 
(red arrowheads). On the sagittal image, polymicrogyria (red circle) at 
the junction of the pachygyric occipital cortex with the parietal lobe is 
seen. (c) Three-dimensional reformatting of magnetic resonance images 
with cortical thickness color mapping shows the occipital cortex to be 
markedly thickened (yellow color, >8 mm) as compared to a control 
subject in which the cortex is less than 4 mm in thickness. (d) The 
retinotopic mapping reveals the anatomical locations of the primary  
visual areas and the spatial patterns of their activity in response to  
visual stimulation in NG 367-1 to be similar to a control subject.  
(e) Diffusion tensor imaging tractography reveals the disorganization 
of short association fibers in the posterior part of the occipital lobe in 
areas adjacent to the pachygyric regions (arrows). cc, corpus callosum; 
ifo, inferior fronto-occipital fasciculus; fm, forceps major; ilf, inferior 
longitudinal fasciculus. (f) Simplified pedigree structure of NG 50 
(arrow, index case) shows a second cousin consanguineous union. (g) The 
axial, coronal and sagittal magnetic resonance imaging reveals occipital 
pachygyria (red arrowheads) in association with polymicrogyric areas. On 
the coronal image in the middle, a cerebrospinal fluid (CSF) cleft, which 
is typically associated with polymicrogyria, is visible (black arrowheads).
Figure 1 LAMC3 mutation in NG 49 with occipital 
cortical malformation. (a) The pedigree structure of NG 49 
(index case, NG 49-1, black arrow) is shown, which 
reveals a first cousin marriage. (b) A sagittal magnetic 
resonance image reveals occipital cortical pachygyria 
(red arrows). (c–f) Coronal (c,d) and axial (e,f) 
magnetic resonance images reveal thickening and 
smoothening of the occipital cortex (red arrows) along 
with polymicrogyria (red arrowheads). Loss of the 
clear distinction between the gray and white matter is 
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staring and blinking spells (Supplementary Note and Supplementary 
Video 3). On her current examination at age 33 years, this subject 
was found to be neurologically intact with normal visual acuity and 
reportedly average intelligence. MRI revealed prominent bilateral 
smoothening and thickening of the lateral occipital cortex, which is 
associated with polymicrogyria (Fig. 2b,c, Supplementary Fig. 3a  
and Supplementary Videos 4 and 5). However, despite these gross 
structural findings, retinotopic mapping using functional MRI indi-
cated that the relative locations and functions of the primary visual 
areas were largely indistinguishable from control subjects (Fig. 2d, 
Supplementary Note and Supplementary Fig. 3b)12,13. Nonetheless, 
diffusion tensor imaging (DTI) tractography showed markedly lower 
fractional anisotropy and elevated radial diffusivity values in areas 
adjacent to the pachygyric region, suggesting microstructural changes 
of white matter, possibly caused by fiber disorganization (Fig. 2e and 
Supplementary Note).
Finally, we investigated the remaining affected individuals in our 
neurogenetics cohort of over 600 people to assess whether any had 
similar MRI findings. We identified only one other individual, NG 
50-1, who had an almost identical MRI picture. This subject was 
the product of a second cousin marriage (Fig. 2f) and presented 
to medical attention at the age of 11 with episodes of vision loss 
consistent with seizures; imaging studies again revealed bilateral 
occipital pachygyria associated with polymicrogyria (Fig. 2g, 
Supplementary Fig. 1b and Supplementary Note). We found NG 50-1 
to be heterozygous for the interval surrounding LAMC3, suggest-
ing potential genetic locus heterogeneity (Supplementary Table 5). 
However, exome sequencing revealed no homozygous nonsense 
or frameshift mutations, whereas all eight new homozygous mis-
sense variants identified affected non-conserved domains of various 
proteins located within the autozygous intervals, suggesting that 
they were unlikely to be disease causing (Supplementary Table 6). 
Subsequent examination of the LAMC3 sequence available from the 
exome sequencing data followed by confirmation using PCR and 
Sanger sequencing identified a compound heterozygous mutation, 
with a premature termination mutation at codon 386 (resulting in 
p.Gln386X) and a missense mutation (resulting in p.Gly350Arg) 
at a position completely conserved among vertebrate orthologs 
(Supplementary Fig. 2c and Supplementary Fig. 4) and predicted 
to be damaging. One mutation was inherited from each parent 
(Supplementary Fig. 2c).
None of the four mutations newly discovered in LAMC3 had been 
previously reported in the dbSNP or 1000 Genomes databases and 
all were absent from our screening of 400 Turkish control subjects. 
They were also absent from our whole-exome sequence database 
of 1,023 subjects with non-neurological diseases in which we only 
identified four different heterozygous LAMC3 variants (p.Cys273Tyr, 
p.Gly275Glu, p.Gln928X and c.976+1G>A) with a collective allele fre-
quency of less than 1 in 500, consistent with these deleterious alleles 
being under strong purifying selection. The rarity of such deleteri-
ous mutations and the finding of new homozygous and compound 
heterozygous mutations in LAMC3 in all three subjects with occipi-
tal pachygyria and polymicrogyria provide conclusive evidence that 
recessive LAMC3 mutations cause this syndrome.
We next investigated the expression of LAMC3 in the developing 
human fetal brain at 20 post-conceptual weeks (PCW) and showed 
that it was enriched in the cortical plate, a dense layer of post-
migratory pyramidal neurons, and was also present at lower levels in 
the ventricular and subventricular zones, the germinal layers of the 
cortex (Fig. 3 and Supplementary Fig. 5). In contrast, we observed 
a strikingly different expression pattern in the embryonic mouse 
brain, where Lamc3 expression was absent from the neuronal cells 
and was instead restricted to the embryonic cerebral vasculature and 
the meninges from embryonic day (E) 13.5 onwards (Fig. 3b and 
Supplementary Fig. 6). This finding, which is consistent with the pre-
vious observation that Lamc3 deletion in mice is silent with no appar-
ent phenotype14, suggested that LAMC3 expression has diverged on 
the mammalian lineage, making the mouse a poor model for under-
standing LAMC3 function in human cortical development.
We then investigated the spatial and temporal changes in expres-
sion during human cortical development and first detected LAMC3 
transcripts after mid-gestation, which peaked at an interval 
 extending from late fetal development to late infancy (12 months) 
(Fig. 4a), coinciding with the period of cortical organization that 
takes place after neural stem cell proliferation and migration of 
postmitotic neurons to the cortical plate. Examination of LAMC3 
expression at the subcellular level supported these observations, 
showing that LAMC3 primarily localizes to the soma and apical 
dendrite of pyramidal neurons (Fig. 4b,c and Supplementary 
Fig. 7) and is barely detected along or near the axons (Fig. 4d). 
A role for LAMC3 in extracellular matrix organization of the soma-
todendritic compartment was further supported by an analysis 
of the Human Brain Transcriptome database15, showing that the 
developmental expression pattern of LAMC3 parallels that of other 
molecules important for dendritogenesis (Fig. 4e)16,17 and syn-
apse formation (Supplementary Note, Supplementary Fig. 8 and 
Supplementary Table 7)18.
Laminins are extracellular cell adhesion molecules mostly local-
izing to basement membranes19 and are essential for early embryonic 
development. They are cross-shaped heterotrimers consisting of α, β 
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Figure 3 Species differences in expression of LAMC3 in the cerebral 
cortex. (a) In situ hybridization of mid-fetal human brain (20 PCW) 
shows robust LAMC3 expression in the cortical plate (CP) and within 
the germinal zones of the neocortical wall, including the ventricular 
zone (VZ) and subventricular zone (SVZ), and the outer SVZ (oSVZ). IZ, 
intermediate zone. (b) In contrast, Lamc3 expression in the developing 
mouse brain (E13.5 to E17.5) is limited to the vasculature and meninges. 
(c) Human fetal neocortex (20 PCW) immunostained for LAMC3 (green), 
the post-mitotic neuronal marker NeuN (red) and the neural stem cell 
marker SOX2 (blue) shows LAMC3 to be strongly expressed in post-mitotic 
NeuN-positive neurons that have migrated and settled in the cortical plate 
(CP). Although LAMC3 is not expressed in the intermediate zone, which 
contains migrating neurons, expression is seen in SOX2-positive neural 
stem cells in the ventricular zone and subventricular zone. In addition, 
LAMC3 is expressed in the basal lamina of blood vessels. Composite 
images are shown on the right. See supplementary Figure 5 for  
individual panels.
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and γ chains. Mutations in various laminin molecules lead to diverse 
pathologies including Pierson syndrome (congenital nephrotic 
syndrome with or without ocular abnormalities caused by LAMB2 
mutations), junctional epidermolysis bullosa (α3, β3 and γ2 chain 
mutations) and congenital merosin-deficient muscular dystrophy 
type 1A (LAMA2 mutations), which is sometimes associated with 
cobblestone lissencephaly and occipital pachygyria19–21. Mutations 
in LAMC3 have not previously been reported. LAMC3 is not thought 
to associate exclusively with the basement membrane—it can bind 
either to nidogen or to α6β1-integrin and is expressed in mouse retina 
and brain vessels22–25, with Lamc3 knockout mice lacking any overt 
phenotypes14,26.
Little is known about the precise molecular mechanisms underly-
ing human cortical gyration. Here we present conclusive genetic evi-
dence that recessive LAMC3 mutations cause human occipital cortical 
malformations characterized by complex gyration abnormalities and 
challenge the concept that cortical smoothening needs to be caused by 
disruption of early events in cortical neuronal migration exclusively. 
Further studies are needed to identify other molecules involved in 
the intricate process of cortical organization and to understand why 
the phenotype associated with LAMC3 mutations is restricted to the 
occipital lobes.
URLs. dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP/; 1000 
Genomes Project, http://www.1000genomes.org/; Human Brain 
Transcriptome database, http://www.humanbraintranscriptome.org/; 
RefSeq, http://www.ncbi.nlm.nih.gov/RefSeq/; DAVID Bioinformatics 
Resources, http://david.abcc.ncifcrf.gov/; Freesurfer, http://surfer.
nmr.mgh.harvard.edu/; Java programming package, http://bilkent.
edu.tr/~hboyaci/PsychWithJava; MedINRIA, http://www-sop.inria.
fr/asclepios/software/MedINRIA/index.php.
MeThods
Methods and any associated references are available in the online 
version of the paper at http://www.nature.com/naturegenetics/.
Accession codes. LAMC3 data are deposited in RefSeq under acces-
sion number NM_006059.
Note: Supplementary information is available on the Nature Genetics website.
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Figure 4 Temporal and spatial LAMC3 
expression pattern. (a) Heat map of LAMC3 
expression in human brain. The strongest 
expression was seen between late gestation 
(24–38 PCW) and late infancy (6–12 post-
natal months) and is more prominent within 
the temporo-occipital lobes as compared to 
frontal regions. PCW, post-conceptual weeks; 
m, month; y, year. #Brain regions sampled 
are listed under Methods. (b) Human fetal 
neocortex (20 PCW) immunostained for 
LAMC3 (green) and the neuronal marker 
SMI-312 (red) reveals high expression in 
pyramidal neurons in a punctate pattern 
primarily localizing to the somata and apical 
dendrites (arrowheads), both at the proximal 
and distal segments. LAMC3 expression is  
not detected on axons as they leave the 
cortical plate (CP) and enter the subplate 
(SP). (c) In cortical layer 2, LAMC3 (green)  
is localized to bundles of distal apical 
dendrites (arrowhead) immuno-positive  
for MAP2 (red), a marker for dendrites.  
(d) In the cortical plate, LAMC3 (green)  
is expressed in pyramidal neurons.  
In the white matter (WM), where bundles  
of SRGAP1-positive corticofugal axons (red) 
are abundantly present, LAMC3 is weak or 
absent on axons but highly expressed in 
the neighboring blood vessels. (e) LAMC3 
expression (black line) parallels that of genes 
known to be expressed during the period of dendritogenesis (blue line) within the V1 visual cortex (V1C) during late fetal and early post-natal 
periods and declines after infancy. For a and e, log2-transformed expression values are shown (Online Methods).
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oNLINe	MeThods
Human subjects. The study protocol was approved by the Yale Human 
Investigation Committee (HIC) (protocol number 0908005592). Institutional 
review board approvals for genetic and MRI studies, along with written consent 
from all study subjects, were obtained by the referring physicians at the participat-
ing institutions. All fetal human tissues were collected under guidelines approved 
by the Yale HIC (protocol number 0605001466). Human fetal brains at 20 and 
22 weeks of gestation were obtained from the Human Fetal Tissue Repository at 
the Albert Einstein College of Medicine (CCI number 1993-042).
Genome-wide genotyping. The Illumina Platform was used for genome-wide 
genotyping and analysis of the samples. Human 610K Quad BeadChips were 
used according to the manufacturer’s protocol (Illumina).
Exome capture and sequencing. NimbleGen 2.1M human exome array 
version 1.0 (Roche Nimblegen, Inc.) was used to capture the exomes of samples 
NG 49-1 and NG 50-1 according to the manufacturer’s protocol, with modifi-
cations11,27. Sequencing of the library was performed on Genome Analyzer IIx 
using a single lane per subject (at a read length of 99 bp and 74 bp for NG 49-1 
and NG 50-1, respectively) (Supplementary Table 2). The Illumina pipeline 
version 1.5 was used for image analysis and base calling.
Exome data analysis. Analysis of the sequencing data was performed accord-
ing to the previously described data analysis pipeline we have developed11,27 
by mapping the reads to the human genome (NCBI36/hg18) by Maq and BWA 
software28,29. Coverage rates and distributions, as well as error positions and 
frequencies, were detected using perl scripts developed in house. Variants 
were called using SAMtools30 and annotated for newness as compared to the 
dbSNP, Personal Genome and 1000 Genomes databases, as well as additional 
exome sequencing experiments we have performed. New variants were further 
evaluated for their impact on the encoded protein, conservation across 44 
vertebrate species and Caenorhabditis elegans and Drosophila melanogaster, 
expression patterns and potential overlap with known miRNAs.
Sanger sequencing. Coding regions and exon-intron boundaries of LAMC3 
were evaluated by Sanger sequencing using standard protocols. Amplicons 
were cycle sequenced on ABI 9800 Fast Thermocyclers, and post cycle 
sequencing clean up was carried out with CleanSEQ System (Beckman Coulter 
Genomics). The amplicons were analyzed on 3730×L DNA Analyzer (Applied 
Biosystems Inc.).
Animals. All protocols performed in animal experiments were approved by 
the Institutional Animal Care and Use Committee at Yale School of Medicine. 
Embryonic day 0.5 was determined as the midday of the day of vaginal plug 
discovery. For embryonic stages, pregnant females were anesthetized, pups at 
appropriate stages were extracted from the uterus and the brains were dissected 
and fixed overnight by immersion in 4% paraformaldehyde in phosphate-
buffered saline. Mouse brains were then cryoprotected in 30% sucrose in 4% 
paraformaldehyde and sectioned in the coronal plane on a Leica sledge cryo-
microtome at 40 µm (Leica Microsystems). Sections were mounted on slides 
and processed with in situ hybridization.
In situ hybridization. Sections were processed for non-radioactive in situ 
hybridization as described previously with minor modifications31,32.
Immunofluorescence. Upon dissection, fetal human brains were immersed 
whole in 4% paraformaldehyde for 36 h, cryoprotected and frozen, and cryo-
sectioned at 60 µm. Standard techniques were used after primary antibodies 
were diluted in blocking solution containing normal donkey serum as fol-
lows: rabbit anti-LAMC3 (R96, W. Brunken, SUNY Downstate), 1:5,000; goat 
anti-SOX2 (Santa Cruz), 1:250; mouse anti-NeuN (Millipore), 1:1,000; mouse 
anti-SMI-312 (Covance), 1:250; mouse anti-MAP2 (Sigma), 1:1,000; and mouse 
anti-SRGAP1 (Abcam), 1:250.
LAMC3 expression. The data were from a unique, high-quality microarray 
dataset that measured gene expression within different brain regions through-
out human life using the Affymetrix Human Exon 1.0 ST arrays15 (see URLs). 
The log2-transformed expression values were calculated. The heat map was 
plotted by averaging the expression of LAMC3 (Laminin γ3) in the samples 
from the same cortical area and stage (Fig. 4a). The following cortical areas 
were sampled: orbital prefrontal cortex (OFC), dorsolateral prefrontal cortex 
(DFC), ventrolateral prefrontal cortex (VFC), medial prefrontal cortex (MFC), 
primary motor (M1) cortex (M1C), primary somatosensory (S1) cortex (S1C), 
posterior inferior parietal cortex (IPC), primary auditory (A1) cortex (A1C), 
posterior superior temporal cortex (STC), inferior temporal cortex (ITC) and 
primary visual (V1) cortex (V1C) (Fig. 4a).
To compare the relationship of LAMC3 expression levels and developmental 
trajectories, functional gene lists for dendrite development (MAP1A, MAPT 
and CAMK2A) (Fig. 4e) and synaptogenesis (SYP, SYPL1, SYPL2 and SYN1) 
(Supplementary Fig. 8) were manually curated. To summarize the principle 
gene expression profile of each category, principal component analysis was per-
formed. The first principle component (PC1), which accounts for the majority 
of variability in the data, was plotted against age (to represent the developmen-
tal trajectory) and LAMC3 expression level. The two independent datasets of 
synaptic density and the number of basal dendrites in the corresponding brain 
regions or areas were scaled by x−m
s
, in which µ and σ are the mean and the 
standard deviation of the values, respectively, corresponding to the time peri-
ods for which both our gene expression and the independently generated data 
were available. The scaled values were plotted against logarithmic age in days, 
and a cubic spline curve was fitted to display the developmental trajectories. 
The predicted values on this curve were calculated corresponding to available 
time points of previously generated independent data on dendrite develop-
ment16,17 and synaptogenesis18. To identify developmentally co-expressed 
genes, we calculated the correlation of the temporal expression pattern of all 
other genes to that of LAMC3. The top 50 genes were selected for functional 
annotation, using DAVID Bioinformatics Resources 6.7 (see URLs)33.
Primary human neuronal cell culture. All experiments were conducted in 
accordance with a protocol approved by the Yale Human Investigation Committee 
(principal investigator, N. Šestan, Protocol# 0605001466). Ventricular zone tissue 
was dissected from fetal human frontoparietal neocortical wall at 19 weeks 
of gestation, enzymatically dissociated and cultured in serum-free media in 
the presence of FGF-2 (20 ng/ml) and epidermal growth factor (20 ng/ml). 
After 4 weeks in culture, neural progenitor cells were transfected with a con-
struct that co-expresses GFP and hemagglutinin (HA)-tagged human LAMC3 
(BC156274) using nucleofection (Lonza, kit VPG-1004; program A-033). One 
day after transfection, growth factors were withdrawn to facilitate neuronal 
differentiation. After 7 days in culture in the absence of growth factors, dif-
ferentiated neurons were fixed and stained for GFP and HA.
MR data acquisition. MRI scanning was performed on a 3 Tesla scanner 
(Magnetom Trio, Siemens AG) with a twelve-channel phase-array head coil. 
A high-resolution T1-weighted three-dimensional anatomical-volume scan 
was acquired for each participant in the same session before the functional and 
DTI scans. BOLD signals in the functional scans were measured with an echo-
planar imaging sequence. DTI data were acquired using a single-shot spin-echo 
echo-planar imaging sequence with parallel imaging technique GRAPPA.
MRI structural analysis procedures. Structural analysis involved three-
dimensional reconstruction of the participants’ cortices and computing 
cortical thickness using the Freesurfer analysis package (see URLs). After 
correction, the cortical thickness was calculated at each point as the short-
est distance between the white matter-gray matter boundary and the gray 
 matter-cerebrospinal fluid boundary. Finally, the cortical thickness measure-
ment results were mapped on the three-dimensional model of the cortex using 
a color coding scheme for visualization.
Retinotopic mapping procedures. Experimental software for the retinotopic 
mapping fMRI scan was written by H.B. and K.D. in the Java programming 
platform (see URLs). In the scanner, the stimuli were back projected by a 
video projector fitted with a long throw lens onto a translucent back projection 
screen placed inside the scanner bore with the help of an angled first surface 
mirror. The functional scans were performed for retinotopic mapping follow-
ing the methods developed by two previous studies34,12.
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Functional images were preprocessed by using the BrainVoyager QX software 
(Brain Innovation BI) and the three-dimensional model of the cortices were 
constructed and inflated for visualization. Functional images from all scans 
were spatially transformed and aligned with the anatomical volume obtained 
in the retinotopic mapping scan individually. Boundaries between retinotopic 
areas were drawn manually with a standard graphics program (Inkscape) after 
visual inspection of the cross-correlation maps of the BOLD response and the 
rotating wedges and of the BOLD response and the expanding annuli12,34. The 
analysis of the second scan of NG 367-1 involved the same steps, except that 
instead of a cross-correlation analysis, we performed a general linear model 
analysis to identify the voxels that respond to vertical or horizontal wedges. We 
then visualized these voxels on the inflated cortex and used this as auxiliary 
information for manually drawing the boundaries between early visual areas.
DTI analysis procedures. White matter pathways were identified using the 
MRI Atlas of Human White Matter35 and fiber tracking was performed in 
MedINRIA software package (see URLs). Fractional Anisotropy and Mean 
Diffusivity maps were computed in DTI studio36 in three manually defined 
region of interest. Initial measurements are reported, and no further statistical 
analysis was performed.
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